Please wait while the formulary information is being retrieved.
ZYMAXID (GATIFLOXACIN)
- Bacterial conjunctivitis
0.5 % eye drops
- Instill 1 drop into affected eye(s) by ophthalmic route 2 times per day while awake on days 2 through 7 of treatment
0.5 % eye drops
- Instill 1 drop into affected eye(s) by ophthalmic route 2 times per day while awake on days 2 through 7 of treatment
Bacterial conjunctivitis
- Instill 1 drop into right eye by ophthalmic route 2 times per day while awake on days 2 through 7 of treatment
- Instill 1 drop into right eye by ophthalmic route 4 times per day while awake on days 2 through 7 of treatment
- Instill 1 drop into left eye by ophthalmic route 2 times per day while awake on days 2 through 7 of treatment
- Instill 1 drop into left eye by ophthalmic route 4 times per day while awake on days 2 through 7 of treatment
- Instill 1 drop into both eyes by ophthalmic route 2 times per day while awake on days 2 through 7 of treatment
- Instill 1 drop into both eyes by ophthalmic route 4 times per day while awake on days 2 through 7 of treatment
- Instill 1 drop into affected eye(s) by ophthalmic route 2 times per day while awake on days 2 through 7 of treatment
- Instill 1 drop into affected eye(s) by ophthalmic route 4 times per day while awake on days 2 through 7 of treatment
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
ZYMAXID (GATIFLOXACIN)
- Bacterial conjunctivitis
- Keratitis
- Dry eye
- Eye tearing
- Ocular pain
- Ocular redness
More Frequent
Severe
Less Severe
- Ocular itching
- Reduced visual acuity
- Dysgeusia
- Eyelid edema
- Headache disorder
- Ocular discharge
- Ocular irritation
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Allergic dermatitis
- Anaphylaxis
- Angioedema
- Chemosis
- Conjunctival hemorrhage
- Dyspnea
- Facial edema
- Hypersensitivity drug reaction
- Laryngeal edema
- Pharyngeal edema
- Stevens-johnson syndrome
- Urticaria
Less Severe
- Blepharitis
- Blurred vision
- Nausea
- Pruritus of skin
- Skin rash
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Gatifloxacin
- Severity Level:
C
- Additional Notes: Reports of arthropathy with quinolones in animal studies;consider risk/benefit
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Gatifloxacin (ophth)
Amount of systemic absorption low;Consider maternal benefit vs. neonatal risk
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Amount of systemic absorption low;Consider maternal benefit vs. neonatal risk |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Bacterial conjunctivitis | |
H10.02 | Other mucopurulent conjunctivitis |
H10.021 | Other mucopurulent conjunctivitis, right eye |
H10.022 | Other mucopurulent conjunctivitis, left eye |
H10.023 | Other mucopurulent conjunctivitis, bilateral |
H10.029 | Other mucopurulent conjunctivitis, unspecified eye |
H10.3 | Unspecified acute conjunctivitis |
H10.30 | Unspecified acute conjunctivitis, unspecified eye |
H10.31 | Unspecified acute conjunctivitis, right eye |
H10.32 | Unspecified acute conjunctivitis, left eye |
H10.33 | Unspecified acute conjunctivitis, bilateral |
0-9 | A-Z |
---|---|
H10.02 | Other mucopurulent conjunctivitis |
H10.021 | Other mucopurulent conjunctivitis, right eye |
H10.022 | Other mucopurulent conjunctivitis, left eye |
H10.023 | Other mucopurulent conjunctivitis, bilateral |
H10.029 | Other mucopurulent conjunctivitis, unspecified eye |
H10.3 | Unspecified acute conjunctivitis |
H10.30 | Unspecified acute conjunctivitis, unspecified eye |
H10.31 | Unspecified acute conjunctivitis, right eye |
H10.32 | Unspecified acute conjunctivitis, left eye |
H10.33 | Unspecified acute conjunctivitis, bilateral |
Formulary Reference Tool